Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Current Opinion in Cardiology|August 23, 2019
Review of cardiovascular outcomes trials of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonistsEmily J North, Jonathan D NewmanCirculation Research|April 25, 2024
Personal Strategies to Reduce the Cardiovascular Impacts of Environmental ExposuresLuke J Bonanni, Jonathan D NewmanAmerican Journal of Hypertension|March 2, 2012
Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension StudyDaichi Shimbo, Jonathan D Newman, Joseph E SchwartzCurrent Opinion in Lipidology|June 8, 2018
Towards more specific treatment for diabetic dyslipidemiaValentina Rodriguez, Jonathan D Newman, Arthur Z SchwartzbardPediatric Emergency Care|February 9, 2005
Screening for intimate-partner violence in the pediatric emergency departmentJonathan D Newman, Karen M Sheehan, Elizabeth C PowellCurrent Atherosclerosis Reports|February 19, 2015
The recent national lipid association recommendations: how do they compare to other established dyslipidemia guidelines?Laura Flink, James A Underberg, Jonathan D Newman, et al.European Heart Journal|November 27, 2012
Emotional triggers in myocardial infarction: do they matter?Donald Edmondson, Jonathan D Newman, William Whang, et al.Journal of the American College of Cardiology|April 25, 2020
Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus SeminarTanya Wilcox, Christophe De Block, Arthur Z Schwartzbard, et al.Diabetes Care|April 6, 2018
Influence of Diabetes on Trends in Perioperative Cardiovascular EventsJonathan D Newman, Tanya Wilcox, Nathaniel R Smilowitz, et al.European Heart Journal. Quality of Care & Clinical Outcomes|December 22, 2020
Diabetes mellitus and outcomes of lower extremity revascularization for peripheral artery diseaseNipun Bhandari, Jonathan D Newman, Jeffrey S Berger, et al.Pageof 11